Drug Type Small molecule drug |
Synonyms Cefotetan disodium (USP), Cefotetan sodium (JAN), ICI-156834 (free acid) + [5] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (27 Dec 1985), |
Regulation- |
Molecular FormulaC17H17N7NaO8S4 |
InChIKeyBTOFDTWBLNLGSY-DWUNWFSHSA-N |
CAS Registry74356-00-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02228 | Cefotetan Disodium |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bone and joint infections | United States | 09 Aug 2007 | |
| Gynecological infection | United States | 09 Aug 2007 | |
| Intraabdominal Infections | United States | 09 Aug 2007 | |
| Lower Respiratory Tract Infections | United States | 09 Aug 2007 | |
| Skin and skin structure infections | United States | 09 Aug 2007 | |
| Urinary Tract Infections | United States | 09 Aug 2007 | |
| Infectious Diseases | United States | 27 Dec 1985 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Complicated intra-abdominal infection | Phase 2 | China | 21 Feb 2017 | |
| Bacterial Infections | Phase 2 | China | 10 Oct 2012 | |
| Genitourinary tract infection | Phase 2 | China | 12 Apr 2012 | |
| Skin Diseases, Infectious | Phase 1 | China | 09 Mar 2015 | |
| Acute Bronchitis | Phase 1 | China | 26 Jul 2011 | |
| Bronchiectasis | Phase 1 | China | 26 Jul 2011 | |
| Bronchitis, Chronic | Phase 1 | China | 26 Jul 2011 | |
| Pneumonia | Phase 1 | China | 26 Jul 2011 |





